journal article·2025-09Open access

The Long Noncoding RNA ΒFaar Promotes White Adipose Tissue Browning and Prevents Diet‐Induced Obesity

Yue Yang, Bin Huang, Baixue Sha, Danni Gao, Yimeng Qin, Ziyi Li, Xi Chen, Yinuo Jin, Yi Pan, Yanfeng Zhang, Yumeng Shen, Yu Liu, Liang Jin, Fangfang Zhang

Advanced Science· Volume 12· Issue 35

Abstract

Abstract The conversion of white adipose tissue (WAT) to brown adipose tissue (BAT) is a promising strategy for obesity treatment. It is previously identified βFaar as a conserved long noncoding RNA (lncRNA) regulator of islet β‐cell function in individuals with obesity, but its effect on WAT browning is not well understood. In this study, it is discovered that βFaar expression in adipose tissue markedly decreases with the progression of obesity in both mice and humans. βFaar in adipose tissue reduces lipid droplet (LD) size in WAT and promotes a browning phenotype in inguinal WAT (iWAT), leading to the amelioration of high‐fat diet (HFD)‐induced obesity. These effects can be attributed to crosstalk between βFaar and proteins within the master regulatory pathways of LD formation and WAT browning, including RAS oncogene family 18 (RAB18) and interferon regulatory factor 4 (IRF4). Specifically, βFaar inhibits LD swelling by binding to RAB18 and promoting IRF4 nuclear translocation, increases uncoupling protein 1 (UCP1) transcription, and further induces iWAT browning by binding to karyopherin subunit alpha 6 (KPNA6). Together, these results demonstrate the critical roles of βFaar in regulating iWAT browning and preserving metabolic health; thus, βFaar may be a potential therapeutic target for management of obesity and related disorders.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Adipose Tissue and Metabolism · Cancer-related molecular mechanisms research · Lipid metabolism and disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Druggability of Biopharmaceuticals, School of Life Science and Technology China Pharmaceutical University 24 Tongjiaxiang Nanjing China

Nanjing HanKai Academy Jiangpu Street, Pukou Nanjing Jiangsu Province China

Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing 211198 China

Endocrinology Department Sir Run Run Hospital of Nanjing Medical University 109# Longmian Road Nanjing 210000 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · China Postdoctoral Science Foundation · Fundamental Research Funds for the Central Universities · Higher Education Discipline Innovation Project

References (46)

Show source-provided references
1. 10.1016/j.cmet.2017.12.00210.1016/j.cmet.2017.12.002 ↗
2. 10.1038/nrd.2016.7510.1038/nrd.2016.75 ↗
3. 10.1210/endrev/bnz00710.1210/endrev/bnz007 ↗
4. 10.1016/j.cmet.2018.11.00210.1016/j.cmet.2018.11.002 ↗
5. 10.1016/j.cell.2021.12.01610.1016/j.cell.2021.12.016 ↗
6. 10.1056/NEJMoa081078010.1056/NEJMoa0810780 ↗
7. 10.1002/dmrr.359410.1002/dmrr.3594 ↗
8. 10.1038/s41574-021-00562-610.1038/s41574-021-00562-6 ↗
9. 10.1038/s41467-018-06462-010.1038/s41467-018-06462-0 ↗
10. 10.1172/jci.insight.14064410.1172/jci.insight.140644 ↗
11. 10.1016/j.cmet.2007.06.00110.1016/j.cmet.2007.06.001 ↗
12. 10.1038/s41580-022-00566-810.1038/s41580-022-00566-8 ↗
13. 10.1016/j.cell.2024.10.02410.1016/j.cell.2024.10.024 ↗
14. 10.1038/s42255-020-0205-x10.1038/s42255-020-0205-x ↗
15. 10.1172/JCI17007210.1172/JCI170072 ↗
16. 10.1038/s41467-021-24302-610.1038/s41467-021-24302-6 ↗
17. 10.1242/jcs.0240110.1242/jcs.02401 ↗
18. 10.1530/JME-12-014010.1530/JME-12-0140 ↗
19. Xu D. · 2021
20. 10.1083/jcb.20170418410.1083/jcb.201704184 ↗
21. 10.1016/j.cell.2014.04.04910.1016/j.cell.2014.04.049 ↗
22. 10.1007/s00125-020-05090-y10.1007/s00125-020-05090-y ↗
23. 10.1016/j.cmet.2015.04.00310.1016/j.cmet.2015.04.003 ↗
24. 10.1073/pnas.122264311010.1073/pnas.1222643110 ↗
25. 10.1016/j.molcel.2014.06.00410.1016/j.molcel.2014.06.004 ↗
26. 10.2337/db22-101610.2337/db22-1016 ↗
27. 10.1038/s42255-022-00631-810.1038/s42255-022-00631-8 ↗
28. 10.1172/JCI4606910.1172/JCI46069 ↗
29. 10.1016/S0968-0004(98)01349-810.1016/S0968-0004(98)01349-8 ↗
30. 10.1083/jcb.20150506710.1083/jcb.201505067 ↗
31. 10.1242/jcs.02545210.1242/jcs.025452 ↗
32. 10.1002/advs.20230334110.1002/advs.202303341 ↗
33. 10.15252/embr.20205128910.15252/embr.202051289 ↗
34. 10.1093/stcltm/szae05610.1093/stcltm/szae056 ↗
35. 10.15252/embr.20225546710.15252/embr.202255467 ↗
36. 10.1016/j.bbalip.2018.01.00810.1016/j.bbalip.2018.01.008 ↗
37. 10.1016/j.bbalip.2018.01.00510.1016/j.bbalip.2018.01.005 ↗
38. Li S. · Proc. Natl. Acad. Sci. USA · 2017 · 114
39. 10.1038/s41419-022-04996-210.1038/s41419-022-04996-2 ↗
40. 10.1038/s41467-021-27171-110.1038/s41467-021-27171-1 ↗
41. 10.1210/endocr/bqad14710.1210/endocr/bqad147 ↗
42. 10.1007/s11154-023-09866-610.1007/s11154-023-09866-6 ↗
43. 10.3892/ijmm.2020.474110.3892/ijmm.2020.4741 ↗
44. 10.1016/j.biochi.2016.10.01310.1016/j.biochi.2016.10.013 ↗
45. 10.2337/db13-031110.2337/db13-0311 ↗
46. 10.1074/jbc.RA120.01370010.1074/jbc.RA120.013700 ↗